Sheldon L. Koenig - Sep 19, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Sheldon L. Koenig
Stock symbol
ESPR
Transactions as of
Sep 19, 2022
Transactions value $
-$23,548
Form type
4
Date filed
9/20/2022, 04:08 PM
Previous filing
Aug 8, 2022
Next filing
Mar 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$23.5K -3.39K -1.68% $6.94 198K Sep 19, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.
F2 Consists of 198,257 shares of common stock held, including 2,880 shares acquired in Esperion's Employee Stock Purchase Plan on August 31, 2022.